Advances in the management of alloimmune thrombocytopenia
- 8 December 2006
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 136 (3) , 366-378
- https://doi.org/10.1111/j.1365-2141.2006.06418.x
Abstract
There have been considerable advances in the clinical and laboratory diagnosis of alloimmune thrombocytopenia (AIT), and its postnatal and antenatal management. The antenatal management of AIT has been particularly problematic, because severe haemorrhage occurs as early as 16 weeks gestation and there is no non-invasive investigation that reliably predicts the severity of AIT in utero. The strategies for antenatal treatment have included the use of serial platelet transfusions that, while effective, are invasive and associated with significant morbidity and mortality. Maternal therapy involving the administration of intravenous immunoglobulin and/or steroids is also effective and associated with fewer risks to the fetus. Significant recent progress has involved refinement of maternal treatment, stratifying it according to the likely severity of AIT based on the history in previous pregnancies. However, the ideal antenatal treatment, which is effective without causing significant side-effects to the mother or fetus, has yet to be determined, and further clinical trials are needed.Keywords
This publication has 64 references indexed in Scilit:
- The cost effectiveness of empiric intravenous immunoglobulin for the antepartum treatment of fetal and neonatal alloimmune thrombocytopeniaAmerican Journal of Obstetrics and Gynecology, 2005
- The dilemma of screening for antibodies against low-frequency human platelet antigensTransfusion, 2005
- Neonatal alloimmune thrombocytopenia due to anti‐HPA 1a antibodies; the level of maternal antibodies predicts the severity of thrombocytopenia in the newbornBJOG: An International Journal of Obstetrics and Gynaecology, 2000
- Management of thrombocytopenia in neonatesBritish Journal of Haematology, 1999
- Management of fetal alloimmune thrombocytopenia-a less invasive option?Journal of Obstetrics and Gynaecology, 1999
- Antenatal Treatment of Neonatal Alloimmune ThrombocytopeniaNew England Journal of Medicine, 1988
- Failure of Antenatal High‐Dose Immunoglobulin to Improve Fetal Platelet Count in Neonatal Allo‐Immune ThrombocytopeniaVox Sanguinis, 1988
- IN-UTERO PLATELET TRANSFUSION FOR ALLOIMMUNE THROMBOCYTOPENIAThe Lancet, 1988
- In Utero Cerebral Hemorrhage in Alloimmune ThrombocytopeniaJournal of Pediatric Hematology/Oncology, 1986
- PRENATAL TREATMENT OF ALLOIMMUNE THROMBOCYTOPENIAThe Lancet, 1984